• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CPI - DEL CARIBE EASYTRAK 2; IMPLANTABLE LEAD

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CPI - DEL CARIBE EASYTRAK 2; IMPLANTABLE LEAD Back to Search Results
Model Number 4518
Device Problems High impedance (1291); Pocket Stimulation (1463)
Patient Problems Muscle Stimulation (1412); Heart Failure (2206); No Known Impact Or Consequence To Patient (2692)
Event Date 02/01/2017
Event Type  malfunction  
Manufacturer Narrative
As no further information concerning this report is expected, our investigation is complete.This investigation will be updated should further information be provided.
 
Event Description
Boston scientific received information that this left ventricular (lv) lead has been exhibiting a gradual rise in pace impedances.The impedances then became high enough to be out of range at greater than 2500 ohms.This lv lead remains in service and the patient is being monitored.No adverse patient effects were reported.
 
Event Description
Additional information was received which indicated reprogramming was performed.However, the patient then felt stimulation.Adjustments were again made to reprogramming which resolved the stimulation.The lv pace impedances are stable.The lead remains in service and the patient is being monitored.No adverse patient effects were reported.
 
Event Description
Additional information was received which indicated this patient has repeatedly skipped their previous appointments and now presented due to heart failure symptoms.The system was checked and it was noted this patient's system was previously programmed to monitor only.Since the bi-ventricular pacing stopped, there have been right ventricular (rv) intrinsic amplitude alerts observed.At this time, the patient was evaluated further and it was determined the heart failure symptoms were due to the patient's atrial fibrillation.Reprogramming was performed to increase rv and lv outputs.The patient is not dependent.No adverse patient effects were reported.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EASYTRAK 2
Type of Device
IMPLANTABLE LEAD
Manufacturer (Section D)
CPI - DEL CARIBE
guidant puerto rico b. v.
dorado PR
Manufacturer (Section G)
CPI - DEL CARIBE
guidant puerto rico b. v.
dorado PR
Manufacturer Contact
tim degroot
4100 hamline ave. n
st. paul, MN 
6515826168
MDR Report Key6931588
MDR Text Key89946794
Report Number2124215-2017-14005
Device Sequence Number1
Product Code NIK
Combination Product (y/n)N
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Reporter Occupation Health Professional
Type of Report Initial,Followup,Followup
Report Date 08/30/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Device Expiration Date02/23/2007
Device Model Number4518
Other Device ID NumberEASYTRAK 2
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? Yes
Initial Date Manufacturer Received 08/02/2017
Initial Date FDA Received10/09/2017
Supplement Dates Manufacturer Received08/09/2017
08/30/2018
Supplement Dates FDA Received10/11/2017
10/08/2018
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured02/23/2005
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Age82 YR
-
-